Stock Scorecard
Stock Summary for Neogen Corp (NEOG) - $12.65 as of 4/25/2024 4:42:27 PM EST
Total Score
8 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NEOG
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NEOG
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NEOG
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for NEOG
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for NEOG
Financial Details for NEOG
Company Overview |
|
|---|---|
| Ticker | NEOG |
| Company Name | Neogen Corp |
| Country | USA |
| Description | Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan. |
| Sector Name | LIFE SCIENCES |
| Industry Name | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Most Recent Quarter | 2/29/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 12.65 |
| Last Day Price Updated | 4/25/2024 4:42:27 PM EST |
| Last Day Volume | 2,533,945 |
| Average Daily Volume | 2,420,596 |
| 52-Week High | 24.09 |
| 52-Week Low | 11.46 |
| Last Price to 52 Week Low | 10.38% |
Valuation Measures |
|
| Trailing PE | 618.50 |
| Industry PE | 227.12 |
| Sector PE | 61.73 |
| 5-Year Average PE | 80.07 |
| Free Cash Flow Ratio | 16.22 |
| Industry Free Cash Flow Ratio | 37.49 |
| Sector Free Cash Flow Ratio | 30.74 |
| Current Ratio Most Recent Quarter | 3.82 |
| Total Cash Per Share | 0.78 |
| Book Value Per Share Most Recent Quarter | 14.53 |
| Price to Book Ratio | 0.85 |
| Industry Price to Book Ratio | 11.27 |
| Sector Price to Book Ratio | 22.08 |
| Price to Sales Ratio Twelve Trailing Months | 2.89 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.80 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
| Total Shares Outstanding | 216,608,000 |
| Market Capitalization | 2,740,091,200 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.19% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -85.60% |
| Annual Earnings Growth | -147.34% |
| Reported EPS 12 Trailing Months | 0.02 |
| Reported EPS Past Year | 0.34 |
| Reported EPS Prior Year | 0.04 |
| Net Income Twelve Trailing Months | 1,566,000 |
| Net Income Past Year | -22,870,000 |
| Net Income Prior Year | 48,307,000 |
| Quarterly Revenue Growth YOY | 4.80% |
| 5-Year Revenue Growth | 14.97% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 168,447,000 |
| Total Cash Past Year | 245,569,000 |
| Total Cash Prior Year | 717,629,000 |
| Net Cash Position Most Recent Quarter | -719,206,000 |
| Net Cash Position Past Year | -1,549,336,000 |
| Long Term Debt Past Year | 1,794,905,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 887,653,000 |
| Equity to Debt Ratio Past Year | 0.64 |
| Equity to Debt Ratio Most Recent Quarter | 0.78 |
| Total Stockholder Equity Past Year | 3,134,217,000 |
| Total Stockholder Equity Prior Year | 887,374,000 |
| Total Stockholder Equity Most Recent Quarter | 3,146,174,000 |
Options |
|
| Put/Call Ratio | 18.17 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.02 |
| MACD Signal | -0.86 |
| 20-Day Bollinger Lower Band | 12.21 |
| 20-Day Bollinger Middle Band | 16.71 |
| 20-Day Bollinger Upper Band | 21.22 |
| Beta | 1.12 |
| RSI | 25.35 |
| 50-Day SMA | 18.33 |
| 200-Day SMA | 29.23 |
System |
|
| Modified | 4/25/2024 6:45:21 AM EST |